The FDA has added a new warning to drugs including Ozempic and Wegovy, cautioning that patients taking the drugs may be at a ...

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...

Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration ...

Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's ...

The U.S. Food and Drug Administration on Friday warned patients and health care professionals not to use compounded drugs, ...

The Food and Drug Administration has updated labels for popular weight loss drugs like Ozempic and Wegovy.

Compounding pharmacies, drugmakers and the FDA share concerns about fake or subpar weight loss drugs — even though regulated compounders often get lumped together with illicit sources by the ...

We’ll help fill some of the gaps, including which FDA-approved diabetes drugs can cause weight loss, how effective they are at reducing and managing body weight, and the possible side effects.

The FDA’s sudden shift highlights challenges regulators and the pharmaceutical industry have faced amid unprecedented demand for the blockbuster weight-loss drugs. “The credibility of the FDA ...